Preclinical Evidence of Berberine on Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Animal Studies.

Front Pharmacol · 2021 · PMC8458904 · PMID 34566663

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

a decreasing trendp = 0.08so close (0.05 < p ≤ 0.1)

However, although we could observe a decreasing trend of HOMA-IR index after BBR treatment, it has no significant difference compared with the model group [ SMD = 2.75, 95% CI (−0.35, 5.85), p = 0.08] ( Table 1 and Supplementary Figure S6C ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.